Description
Founded in 2010, Inkef Capital is a venture capital investment firm based in Amsterdam, Netherlands. The firm prefers to invest in companies operating in the healthcare and technology sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
QurAlis | 09-Mar-2023 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 0000 00000000 |
0000000 000000 | 20-Feb-2023 | 00000 00000 | 000.00 | Application Specific Semiconductors | Generating Revenue | 000000 000 000000 |
00000000 | 01-Aug-2022 | 00000 00000 | 00.00 | Surgical Devices | Clinical Trials - General | 00000000 0ö00000 |
000000 | 07-Jul-2022 | 00000 00000 | 0000 | Business/Productivity Software | Generating Revenue | |
0000000 | 08-Jun-2022 | 0000 00000 | 00.000 | Software Development Applications | Generating Revenue | |
00000000 | 16-Mar-2022 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 000000 00000 00.0 |
0000000000000 | 15-Mar-2022 | 00000 00000 | 0000 | Business/Productivity Software | Generating Revenue | 00000 0000 |
000000 0000000 | 10-Mar-2022 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 0000 00000000 |
TargED | 18-Feb-2022 | Early Stage VC | 000.00 | Drug Discovery | Pre-Clinical Trials | |
NMD Pharma | 15-Feb-2022 | Later Stage VC | 000.00 | Drug Discovery | Generating Revenue | 0000 00000000 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Cashforce | 15-Jun-2022 | Merger/Acquisition | 000.00 |
000000000 00 | 25-Apr-2022 | 0000000000 | |
000000 | 28-Feb-2022 | 000000000000000000 | 00000 |
0000000 | 20-Jan-2022 | 000000000000000000 | 000.00 |
000000 (0000000000 | 21-Oct-2021 | 000 | 000.00 |
000000 | 14-Oct-2021 | 000 | 00000 |
00000 000000000000 | 21-Sep-2021 | 000000000000000000 | |
00000 (0000000000 | 01-Jun-2021 | 000000000 00000000 | |
Bloomon | 22-Apr-2021 | Merger/Acquisition | |
Rainier Therapeutics | 04-Mar-2021 | Out of Business |
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Wolfgang Nöldeke | Chief Financial Officer | 0 | Amsterdam, Netherlands | ||
Roel Bulthuis | Managing Partner & Head, Healthcare Investment Team | 00 | 0 | 0 | Amsterdam, Netherlands |
Robert Jan Galema | Managing Partner | 0 | 0 | Amsterdam, Netherlands | |
Cornelis Jansen | Venture Partner | 0 | 0 | Amsterdam, Netherlands | |
Thijs Cohen Tervaert MD | Junior Partner | 0 | 0 | 0 | Amsterdam, Netherlands |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
EQT Life Sciences | 5 | 0 |
![]() |
![]() |
|
BioGeneration Ventures | 0 | 0 |
![]() |
![]() |
|
BioMedPartners | 0 | 0 |
![]() |
![]() |
|
M Ventures | 0 | 0 |
![]() |
![]() |
|
Novo Holdings | 0 | 0 |
![]() |
![]() |